Partners Powering Progress in Thoracic Oncology
Corporate partners are the backbone of what makes so much of IASLC’s work possible. In 2025, IASLC continued to advance a partnership strategy centered on long-term collaboration and shared purpose.
A highlight of IASLC’s partnership efforts in 2025 was the continued work on IASLC’s Global Biomarker Health Systems Project, which built on the results of 2024’s Global Survey on Biomarker Testing. In 2025, site visits were made to health systems in India and Poland to better understand global barriers to biomarker testing.
The project is rooted in a broader initiative to understand how biomarker testing is implemented worldwide and why gaps persist despite advances in precision oncology.
Matt Smeltzer talks about how crucial the Partners for Thoracic Cancer Care is to the IASLC's mission.